Abstract:Abstract Background： Studies have shown that osteonecrosis of the femoral head (ONFH)is related to bone marrow mesenchymal stem cell injury and microvascular injury. Early ONFH patients can choose core decompression and other treatments, but the clinical effect is poor. In recent years, tissue engineering technology based on mesenchymal stem cells is a new method to treat ONFH. In addition, whether the transplantation area is fully vascularized also affects whether the mesenchymal stem cells can play a repair role. In this study, we constructed prevascularized bone tissue based on human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells to evaluate the therapeutic effect of prevascularized bone tissue on ONFH. Objective: This paper is to investigate the effect of pre-vascularized bone tissue constructed by human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells on bone repair of necrotic femoral head, so as to provide theoretical basis for clinical treatment of necrotic femoral head. Methods: The rabbits were randomly divided into 5 groups, of which, 1 group was not given any intervention, while rabbit femoral head necrosis models were prepared for the other 4 groups by microwave heating method and they are respectively named mould-making group, static bone tissue group, dynamic bone tissue group and pre-vascularized bone tissue group according to the different substances injected into the femoral head. Various tests, including MRI, Micro-CT, HE staining and immunofluorescence staining, were performed after the animals were executed 8 weeks after treatment to assess the osteogenic ability of the implant and the repair effect of necrotic femoral head. Results: Various tests showed that the pre-vascularized bone tissue group had better ability to promote necrotic femoral head repair, and significant new bone formation and bone quality improvement occurred 8 weeks after surgery. The static bone tissue group and dynamic bone tissue group were similar in their ability to promote femoral head repair, with all the three groups outperforming the modeled group. Conclusions: The pre-vascularized bone tissue has a good effect on promoting the reconstruction of necrotic femoral head and shows superior osteogenesis, angiogenesis and bone repair effect. It is thus a good graft material for repairing necrotic femoral head and is of great value in the treatment of necrotic femoral head.

Human umbilical cord mesenchymal stem cells promote steroid-induced osteonecrosis of the femoral head repair by improving microvascular endothelial cell function

Human Umbilical Cord Mesenchymal Stem Cells Prevent Steroid-Induced Avascular Necrosis of the Femoral Head by Modulating Cellular Autophagy

The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head

Human umbilical cord mesenchymal stem cells protect MC3T3-E1 osteoblasts from dexamethasone-induced apoptosis via induction of the Nrf2-ARE signaling pathway

Protective Effect of Human Umbilical Cord Mesenchymal Stem Cells in Glucocorticoid-induced Osteonecrosis of Femoral Head

Bone Regeneration and Angiogenesis by Co-transplantation of Angiotensin II–Pretreated Mesenchymal Stem Cells and Endothelial Cells in Early Steroid-Induced Osteonecrosis of the Femoral Head

Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell-Based Therapy for Osteonecrosis of the Femoral Head: A Three-Year Follow-Up Study

The Effect of Bone Marrow Mononuclear Cells on Vascularization and Bone Regeneration in Steroid-Induced Osteonecrosis of the Femoral Head

Beneficial Effect of Autologous Transplantation of Endothelial Progenitor Cells on Steroid-Induced Femoral Head Osteonecrosis in Rabbits.

Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs

Exosomes from bone marrow mesenchymal stem cells ameliorate glucocorticoid-induced osteonecrosis of femoral head by transferring microRNA-210 into bone microvascular endothelial cells

Reprogrammed Mesenchymal Stem Cells Derived from Ipscs Promote Bone Repair in Steroid-Associated Osteonecrosis of the Femoral Head

Exosomes secreted from mutant-HIF-1α-modified bone-marrow-derived mesenchymal stem cells attenuate early steroid-induced avascular necrosis of femoral head in rabbit

Copper-Lithium-Doped Nanohydroxyapatite Modulates Mesenchymal Stem Cells Homing to Treat Glucocorticoids-Related Osteonecrosis of the Femoral Head

Preclinical models for studying corticosteroid-induced osteonecrosis of the femoral head

Experimental Study of Core Decompression and Autografting Bone Marrow Derived Mesenchymal Stem Cell on Corticosteroid-Induced Femoral Head Osteonecrosis in Rabbits

Effect of Bone Mesenchymal Stem Cells Transplantation on the Micro-Environment of Early Osteonecrosis of the Femoral Head.

Hif-1 Alpha Transgenic Bone Marrow Cells Can Promote Tissue Repair In Cases Of Corticosteroid-Induced Osteonecrosis Of The Femoral Head In Rabbits

Treatment of osteonecrosis of the femoral head using prevascularized bone tissues constructed with human umbilical cord mesenchymal stem cells and human umbilical vein endothelial cells

Cajan leaf combined with bone marrow-derived mesenchymal stem cells for the treatment of osteonecrosis of the femoral head.

HIF-1α transgenic bone marrow cells can promote tissue repair in cases of corticosteroid-induced osteonecrosis of the femoral head in rabbits